[组件解决诊断:提高精确诊断和贝类过敏的临床管理]
1Department of Clinical Laboratory of the First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou 510120, China.
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
|September 18, 2024
概括
贝类过敏影响全球3%的病例,诊断因交叉反应性而复杂化. 过敏原成分诊断为贝类过敏管理提供了个性化的治疗计划.
科学领域:
- 食物过敏研究 食物过敏研究
- 临床免疫学 临床免疫学
- 分子过敏学分子过敏学
背景情况:
- 贝类过敏影响全球约3%的人口,受遗传学,环境和饮食的影响.
- 甲类动物和软体动物虽然都是贝类,但在生物学上和过敏原蛋白质上有所不同,导致各种反应.
- 关键的过敏原包括菌素,氨酸激酶和血清素,对粉尘和昆虫的交叉反应使诊断复杂化.
研究的目的:
- 解释欧洲过敏和临床免疫学会的"分子过敏学用户指南2.0" (MAUG 2.0).
- 审查当前关于贝类过敏的国内和国际研究.
- 强调过敏原成分诊断在改善贝类过敏诊断和管理中的作用.
主要方法:
- 文献审查和MAUG 2.0指南的解释.
- 对贝类过敏原和交叉反应性的当前研究进行分析.
- 专注于过敏原成分诊断,以识别特定的过敏原蛋白质.
主要成果:
- 准确识别过敏性蛋白质,如热菌素,对于诊断至关重要.
- 与其他过敏原的交叉反应使贝类过敏管理复杂化.
- 过敏原成分诊断有助于精确的过敏原识别和交叉反应评估.
结论:
- 目前的管理依赖于避免过敏原和药物治疗;没有特定的免疫疗法.
- 过敏原成分诊断对于优化诊断和治疗至关重要.
- 对贝类过敏患者的个性化诊断和治疗计划可以通过先进的诊断来实现.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
323
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
323
Allergic Reactions
27.3K
Overview
27.3K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
245
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
245


